PepGen (PEPG) News Today $1.37 -0.07 (-4.86%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.31 -0.06 (-4.38%) As of 02/21/2025 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period PepGen stock plunges to 52-week low at $1.16 amid market challengesFebruary 13, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPGFebruary 4, 2025 | prnewswire.comPepGen announces CONNECT program updatesJanuary 31, 2025 | markets.businessinsider.comH.C. Wainwright cuts PepGen stock target to $16, maintains Buy ratingJanuary 31, 2025 | msn.comFY2029 Earnings Estimate for PepGen Issued By HC WainwrightPepGen Inc. (NASDAQ:PEPG - Free Report) - Investment analysts at HC Wainwright issued their FY2029 earnings per share estimates for shares of PepGen in a report issued on Thursday, January 30th. HC Wainwright analyst A. Fein forecasts that the company will post earnings per share of ($0.21) for tJanuary 31, 2025 | marketbeat.comCautiously Optimistic Buy Rating for PepGen Inc. Amid Safety Concerns and Positive Pipeline ProgressJanuary 31, 2025 | markets.businessinsider.comPepGen continues trials for DMD treatment, addresses safety concernsJanuary 31, 2025 | msn.comPepGen Inc. (PEPG) Gets a Buy from Stifel NicolausJanuary 31, 2025 | markets.businessinsider.comPepGen price target lowered to $16 from $26 at H.C. WainwrightJanuary 31, 2025 | markets.businessinsider.comPepGen stock plunges to 52-week low of $1.76 amid market challengesJanuary 31, 2025 | msn.comPepGen (NASDAQ:PEPG) Price Target Lowered to $16.00 at HC WainwrightHC Wainwright dropped their price target on PepGen from $26.00 to $16.00 and set a "buy" rating for the company in a report on Thursday.January 30, 2025 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPGJanuary 28, 2025 | prnewswire.comPepGen stock hits 52-week low at $2.21 amid market challengesJanuary 21, 2025 | msn.comPepGen Inc. (NASDAQ:PEPG) Short Interest Down 14.1% in DecemberPepGen Inc. (NASDAQ:PEPG - Get Free Report) saw a large drop in short interest in December. As of December 31st, there was short interest totalling 694,200 shares, a drop of 14.1% from the December 15th total of 808,100 shares. Based on an average daily volume of 159,500 shares, the short-interest ratio is currently 4.4 days. Approximately 2.6% of the company's stock are short sold.January 16, 2025 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPGJanuary 8, 2025 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPGJanuary 2, 2025 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. ...December 28, 2024 | gurufocus.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPGDecember 27, 2024 | prnewswire.comWedbush Forecasts PepGen's FY2028 Earnings (NASDAQ:PEPG)PepGen Inc. (NASDAQ:PEPG - Free Report) - Equities research analysts at Wedbush raised their FY2028 earnings per share (EPS) estimates for shares of PepGen in a report released on Monday, December 16th. Wedbush analyst L. Chico now expects that the company will post earnings of ($1.85) per shareDecember 19, 2024 | marketbeat.comFmr LLC Sells 327,160 Shares of PepGen Inc. (NASDAQ:PEPG)Fmr LLC decreased its position in shares of PepGen Inc. (NASDAQ:PEPG - Free Report) by 84.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 61,607 shares of the company's stock after selling 3December 19, 2024 | marketbeat.comNovo builds up manufacturing; Pepgen Duchenne trial put on holdDecember 17, 2024 | yahoo.comBofA downgrades PepGen to Underperform after clinical holdDecember 17, 2024 | markets.businessinsider.comPepGen stock down 22% on FDA clinical hold (update)December 17, 2024 | msn.comPepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular DystrophyDecember 17, 2024 | finance.yahoo.comPepGen (NASDAQ:PEPG) Stock Rating Lowered by Bank of AmericaBank of America downgraded shares of PepGen from a "neutral" rating to an "underperform" rating and set a $3.00 price target for the company. in a report on Monday.December 16, 2024 | marketbeat.comPepGen Shares Tumble Premarket as FDA Puts Study on Clinical HoldDecember 16, 2024 | marketwatch.comPepGen Inc. (NASDAQ:PEPG) Shares Sold by Frazier Life Sciences Management L.P.Frazier Life Sciences Management L.P. lessened its stake in PepGen Inc. (NASDAQ:PEPG - Free Report) by 53.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 702,694 shares of the company's stock after selling 800,094 shares during the quaDecember 10, 2024 | marketbeat.comJanus Henderson Group PLC Increases Stock Position in PepGen Inc. (NASDAQ:PEPG)Janus Henderson Group PLC grew its position in shares of PepGen Inc. (NASDAQ:PEPG - Free Report) by 331.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,336,516 shares of the company's stock after acquirDecember 8, 2024 | marketbeat.comPepGen Inc. (NASDAQ:PEPG) Shares Bought by Suvretta Capital Management LLCSuvretta Capital Management LLC lifted its position in shares of PepGen Inc. (NASDAQ:PEPG - Free Report) by 9.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,660,932 shares of the company's stock after buying an additiNovember 29, 2024 | marketbeat.comTwo new option listings and one option delisting on November 21stNovember 22, 2024 | markets.businessinsider.comPepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical DevelopmentNovember 21, 2024 | businesswire.comPepGen price target lowered to $6 from $10 at BofANovember 18, 2024 | markets.businessinsider.comPepGen (NASDAQ:PEPG) Price Target Cut to $6.00 by Analysts at Bank of AmericaBank of America reduced their target price on PepGen from $10.00 to $6.00 and set a "neutral" rating on the stock in a report on Monday.November 18, 2024 | marketbeat.comFY2024 EPS Estimates for PepGen Boosted by Leerink PartnrsPepGen Inc. (NASDAQ:PEPG - Free Report) - Research analysts at Leerink Partnrs upped their FY2024 earnings per share (EPS) estimates for PepGen in a note issued to investors on Sunday, November 10th. Leerink Partnrs analyst J. Schwartz now expects that the company will earn ($2.91) per share forNovember 13, 2024 | marketbeat.comPepGen Inc. Receives ‘Buy’ Rating Amid Promising Genetic Medicine Advances and Undervalued Stock PositionNovember 13, 2024 | markets.businessinsider.comPepGen Inc. (PEPG) Receives a Buy from Stifel NicolausNovember 11, 2024 | markets.businessinsider.comNewpark Resources Reports Q3 2024 Financial ResultsNovember 9, 2024 | markets.businessinsider.comPepGen (NASDAQ:PEPG) Price Target Cut to $12.00 by Analysts at WedbushWedbush dropped their target price on shares of PepGen from $19.00 to $12.00 and set an "outperform" rating for the company in a report on Friday.November 8, 2024 | marketbeat.comHC Wainwright Reiterates Buy Rating for PepGen (NASDAQ:PEPG)HC Wainwright reissued a "buy" rating and issued a $26.00 price objective on shares of PepGen in a research report on Friday.November 8, 2024 | marketbeat.comPepGen Announces Presentations at the 29th Annual Congress of the World Muscle SocietyOctober 8, 2024 | finance.yahoo.comPepGen (NASDAQ:PEPG) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comCapricor Therapeutics Is Up Over 100%, Could Rise Even Higher (PEPG)Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like iomyopathySeptember 30, 2024 | marketbeat.comPepGen director Christopher Ashton to retire at month's endSeptember 21, 2024 | uk.investing.comPepGen Announces Christopher Ashton, PhD, to Retire from its Board of DirectorsSeptember 19, 2024 | finance.yahoo.comPepGen Announces Christopher Ashton, PhD, to Retire from its Board of DirectorsSeptember 19, 2024 | businesswire.comSofinnova Investments Inc. Raises Stake in PepGen Inc. (NASDAQ:PEPG)Sofinnova Investments Inc. grew its holdings in PepGen Inc. (NASDAQ:PEPG - Free Report) by 11.4% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 561,128 shares of the company's stock after buying an additional 57,504 shares during the period. Sofinnova InSeptember 17, 2024 | marketbeat.comThe Schall Law Firm Is Looking Into PepGen Inc. For Possible Securities Law Infractions And Investors Are Invited To Lend A HandSeptember 11, 2024 | stockhouse.comPepGen (NASDAQ:PEPG) Stock Price Down 0.4%PepGen (NASDAQ:PEPG) Trading Down 0.4%September 5, 2024 | marketbeat.comPepGen Inc Is Being Investigated For Securities Law Infractions And The Schall Law Firm Is Looking For Shareholders To ParticipateAugust 25, 2024 | stockhouse.comPepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & DevelopmentAugust 21, 2024 | finance.yahoo.com Get PepGen News Delivered to You Automatically Sign up to receive the latest news and ratings for PEPG and its competitors with MarketBeat's FREE daily newsletter. Email Address PEPG Media Mentions By Week PEPG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PEPG News Sentiment▼0.000.60▲Average Medical News Sentiment PEPG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PEPG Articles This Week▼02▲PEPG Articles Average Week Get PepGen News Delivered to You Automatically Sign up to receive the latest news and ratings for PEPG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Inhibikase Therapeutics News Greenwich LifeSciences News Innate Pharma News Fate Therapeutics News Checkpoint Therapeutics News Solid Biosciences News MacroGenics News Organigram News Nkarta News ADC Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PEPG) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 financial crisis over a year in advance. His readers had a chance to lock in g...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PepGen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PepGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
